Michaela Ott
Directeur/Bestuurslid bij Medite Enterprise, Inc.
Actieve functies van Michaela Ott
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Medite Enterprise, Inc.
Medite Enterprise, Inc. Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite Enterprise, Inc. develops diagnostics and therapeutic medical devices. The company is based in Orlando, FL. Michael Egbert Ott has been the CEO of the company since 2013. Medite Enterprise was acquired by CytoCore, Inc. on April 04, 2014 for $342 million. | Directeur/Bestuurslid | 01-01-2013 | - |
Loopbaan van Michaela Ott
Eerdere bekende functies van Michaela Ott
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MEDITE CANCER DIAGNOSTICS INC | Directeur/Bestuurslid | 03-04-2014 | 17-01-2018 |
Algemeen Directeur | 03-04-2014 | 26-10-2016 | |
Operationeel Directeur | 26-10-2016 | 04-05-2017 | |
Medite GmbH /Austria/
Medite GmbH /Austria/ Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a company based in Salzburg, Austria. Medite GmbH develops diagnostics and therapeutic medical devices. | Algemeen Directeur | - | 30-09-2017 |
MEDITE GmbH
MEDITE GmbH Medical DistributorsDistribution Services Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a German company that develops diagnostics and therapeutic medical devices. The company is based in Niedersachsen, Germany. The CEO of the company is Elmar A. Dave. | President | 01-01-2006 | 04-05-2017 |
CytoCore, Inc.
CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Algemeen Directeur | 03-04-2014 | - |
Statistieken
Internationaal
Verenigde Staten | 4 |
Duitsland | 2 |
Oostenrijk | 2 |
Operationeel
Chief Executive Officer | 3 |
Director/Board Member | 2 |
President | 1 |
Sectoraal
Health Technology | 5 |
Distribution Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MEDITE CANCER DIAGNOSTICS INC | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
CytoCore, Inc.
CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Health Technology |
Medite Enterprise, Inc.
Medite Enterprise, Inc. Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite Enterprise, Inc. develops diagnostics and therapeutic medical devices. The company is based in Orlando, FL. Michael Egbert Ott has been the CEO of the company since 2013. Medite Enterprise was acquired by CytoCore, Inc. on April 04, 2014 for $342 million. | Health Technology |
MEDITE GmbH
MEDITE GmbH Medical DistributorsDistribution Services Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a German company that develops diagnostics and therapeutic medical devices. The company is based in Niedersachsen, Germany. The CEO of the company is Elmar A. Dave. | Distribution Services |
Medite GmbH /Austria/
Medite GmbH /Austria/ Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a company based in Salzburg, Austria. Medite GmbH develops diagnostics and therapeutic medical devices. | Health Technology |
- Beurs
- Insiders
- Michaela Ott
- Ervaring